Discovery	O
of	O
novel	O
antagonists	B:C0243076
of	O
human	O
neurotensin	I:C1741785
receptor	I:C1741785
1	I:C1741785
on	O
the	O
basis	O
of	O
ligand	O
and	O
protein	O
structure	I:C1510464
.	O

Discovery	O
of	O
novel	O
antagonists	O
of	O
human	B:C1741785
neurotensin	I:C1741785
receptor	I:C1741785
1	I:C1741785
on	O
the	O
basis	O
of	O
ligand	O
and	O
protein	O
structure	I:C1510464
.	O

Discovery	O
of	O
novel	O
antagonists	O
of	O
human	O
neurotensin	I:C1741785
receptor	I:C1741785
1	I:C1741785
on	O
the	O
basis	O
of	O
ligand	B:C0023688
and	O
protein	O
structure	I:C1510464
.	O

Discovery	O
of	O
novel	O
antagonists	O
of	O
human	O
neurotensin	I:C1741785
receptor	I:C1741785
1	I:C1741785
on	O
the	O
basis	O
of	O
ligand	O
and	O
protein	B:C1510464
structure	I:C1510464
.	O

Neurotensin	B:C0756552
receptor	I:C0756552
1	I:C0756552
(	O
Neurotensin	O
receptor	I:C0756552
1	I:C0756552
)	O
is	O
a	O
cell	O
surface	I:C0034800
receptor	I:C0034800
belonging	O
to	O
the	O
G	O
protein	I:C0682972
-	I:C0682972
coupled	I:C0682972
receptor	I:C0682972
(	O
G	O
protein	I:C0682972
-	I:C0682972
coupled	I:C0682972
receptor	I:C0682972
)	O
A	O
superfamily	O
.	O

Neurotensin	O
receptor	I:C0756552
1	I:C0756552
(	O
Neurotensin	B:C0756552
receptor	I:C0756552
1	I:C0756552
)	O
is	O
a	O
cell	O
surface	I:C0034800
receptor	I:C0034800
belonging	O
to	O
the	O
G	O
protein	I:C0682972
-	I:C0682972
coupled	I:C0682972
receptor	I:C0682972
(	O
G	O
protein	I:C0682972
-	I:C0682972
coupled	I:C0682972
receptor	I:C0682972
)	O
A	O
superfamily	O
.	O

Neurotensin	O
receptor	I:C0756552
1	I:C0756552
(	O
Neurotensin	O
receptor	I:C0756552
1	I:C0756552
)	O
is	O
a	O
cell	B:C0034800
surface	I:C0034800
receptor	I:C0034800
belonging	O
to	O
the	O
G	O
protein	I:C0682972
-	I:C0682972
coupled	I:C0682972
receptor	I:C0682972
(	O
G	O
protein	I:C0682972
-	I:C0682972
coupled	I:C0682972
receptor	I:C0682972
)	O
A	O
superfamily	O
.	O

Neurotensin	O
receptor	I:C0756552
1	I:C0756552
(	O
Neurotensin	O
receptor	I:C0756552
1	I:C0756552
)	O
is	O
a	O
cell	O
surface	I:C0034800
receptor	I:C0034800
belonging	O
to	O
the	O
G	B:C0682972
protein	I:C0682972
-	I:C0682972
coupled	I:C0682972
receptor	I:C0682972
(	O
G	O
protein	I:C0682972
-	I:C0682972
coupled	I:C0682972
receptor	I:C0682972
)	O
A	O
superfamily	O
.	O

Neurotensin	O
receptor	I:C0756552
1	I:C0756552
(	O
Neurotensin	O
receptor	I:C0756552
1	I:C0756552
)	O
is	O
a	O
cell	O
surface	I:C0034800
receptor	I:C0034800
belonging	O
to	O
the	O
G	O
protein	I:C0682972
-	I:C0682972
coupled	I:C0682972
receptor	I:C0682972
(	O
G	B:C0682972
protein	I:C0682972
-	I:C0682972
coupled	I:C0682972
receptor	I:C0682972
)	O
A	O
superfamily	O
.	O

Neurotensin	B:C0756552
receptor	I:C0756552
1	I:C0756552
plays	O
an	O
important	O
role	O
in	O
neuronal	O
and	O
non	O
-	O
neuronal	O
systems	I:C0027763
.	O

Neurotensin	O
receptor	I:C0756552
1	I:C0756552
plays	O
an	O
important	O
role	O
in	O
neuronal	B:C0027763
and	O
non	O
-	O
neuronal	O
systems	I:C0027763
.	O

Neurotensin	O
receptor	I:C0756552
1	I:C0756552
plays	O
an	O
important	O
role	O
in	O
neuronal	O
and	O
non	O
-	O
neuronal	B:C0027763
systems	I:C0027763
.	O

Using	O
the	O
previously	O
identified	O
crystal	B:C0230587
structure	I:C0230587
of	O
rat	O
NTR1	I:C1738937
(	O
rat	O
NTR1	I:C1738937
)	O
,	O
we	O
screened	O
for	O
potential	O
candidates	O
of	O
human	O
NTR1	I:C1741785
(	O
human	O
NTR1	I:C1741785
)	O
ligand	O
.	O

Using	O
the	O
previously	O
identified	O
crystal	O
structure	I:C0230587
of	O
rat	B:C1738937
NTR1	I:C1738937
(	O
rat	O
NTR1	I:C1738937
)	O
,	O
we	O
screened	O
for	O
potential	O
candidates	O
of	O
human	O
NTR1	I:C1741785
(	O
human	O
NTR1	I:C1741785
)	O
ligand	O
.	O

Using	O
the	O
previously	O
identified	O
crystal	O
structure	I:C0230587
of	O
rat	O
NTR1	I:C1738937
(	O
rat	B:C1738937
NTR1	I:C1738937
)	O
,	O
we	O
screened	O
for	O
potential	O
candidates	O
of	O
human	O
NTR1	I:C1741785
(	O
human	O
NTR1	I:C1741785
)	O
ligand	O
.	O

Using	O
the	O
previously	O
identified	O
crystal	O
structure	I:C0230587
of	O
rat	O
NTR1	I:C1738937
(	O
rat	O
NTR1	I:C1738937
)	O
,	O
we	O
screened	O
for	O
potential	O
candidates	O
of	O
human	B:C1741785
NTR1	I:C1741785
(	O
human	O
NTR1	I:C1741785
)	O
ligand	O
.	O

Using	O
the	O
previously	O
identified	O
crystal	O
structure	I:C0230587
of	O
rat	O
NTR1	I:C1738937
(	O
rat	O
NTR1	I:C1738937
)	O
,	O
we	O
screened	O
for	O
potential	O
candidates	O
of	O
human	O
NTR1	I:C1741785
(	O
human	B:C1741785
NTR1	I:C1741785
)	O
ligand	O
.	O

Using	O
the	O
previously	O
identified	O
crystal	O
structure	I:C0230587
of	O
rat	O
NTR1	I:C1738937
(	O
rat	O
NTR1	I:C1738937
)	O
,	O
we	O
screened	O
for	O
potential	O
candidates	O
of	O
human	O
NTR1	I:C1741785
(	O
human	O
NTR1	I:C1741785
)	O
ligand	B:C0023688
.	O

Approximately	O
10,000	O
compounds	O
were	O
selected	O
using	O
the	O
docking	B:C1522290
score	O
,	O
followed	O
by	O
pharmacophore	O
-	O
based	O
virtual	O
screening	I:C1516769
and	O
a	O
two	O
-	O
dimensional	O
(	O
2D	I:C0022885
)	I:C0022885
-	I:C0022885
fingerprint	I:C0022885
structural	I:C0022885
similarity	I:C0022885
search	I:C0022885
.	O

Approximately	O
10,000	O
compounds	O
were	O
selected	O
using	O
the	O
docking	O
score	O
,	O
followed	O
by	O
pharmacophore	O
-	O
based	O
virtual	B:C1516769
screening	I:C1516769
and	O
a	O
two	O
-	O
dimensional	O
(	O
2D	I:C0022885
)	I:C0022885
-	I:C0022885
fingerprint	I:C0022885
structural	I:C0022885
similarity	I:C0022885
search	I:C0022885
.	O

Approximately	O
10,000	O
compounds	O
were	O
selected	O
using	O
the	O
docking	O
score	O
,	O
followed	O
by	O
pharmacophore	O
-	O
based	O
virtual	O
screening	I:C1516769
and	O
a	O
two	O
-	O
dimensional	O
(	B:C0022885
2D	I:C0022885
)	I:C0022885
-	I:C0022885
fingerprint	I:C0022885
structural	I:C0022885
similarity	I:C0022885
search	I:C0022885
.	O

The	O
identified	O
molecules	O
were	O
tested	O
by	O
in	O
vitro	O
calcium	B:C1510438
flux	I:C1510438
assay	I:C1510438
.	O

Four	O
compounds	O
showed	O
micromolar	O
level	O
affinity	O
,	O
of	O
which	O
,	O
one	O
compound	O
can	O
inhibit	O
human	B:C1741785
NTR1	I:C1741785
/	O
CHO	O
cells	I:C0085080
'	O
proliferation	O
by	O
cell	O
viability	I:C0242481
assays	I:C0242481
.	O

Four	O
compounds	O
showed	O
micromolar	O
level	O
affinity	O
,	O
of	O
which	O
,	O
one	O
compound	O
can	O
inhibit	O
human	O
NTR1	I:C1741785
/	O
CHO	B:C0085080
cells	I:C0085080
'	O
proliferation	O
by	O
cell	O
viability	I:C0242481
assays	I:C0242481
.	O

Four	O
compounds	O
showed	O
micromolar	O
level	O
affinity	O
,	O
of	O
which	O
,	O
one	O
compound	O
can	O
inhibit	O
human	O
NTR1	I:C1741785
/	O
CHO	O
cells	I:C0085080
'	O
proliferation	B:C0596290
by	O
cell	O
viability	I:C0242481
assays	I:C0242481
.	O

Four	O
compounds	O
showed	O
micromolar	O
level	O
affinity	O
,	O
of	O
which	O
,	O
one	O
compound	O
can	O
inhibit	O
human	O
NTR1	I:C1741785
/	O
CHO	O
cells	I:C0085080
'	O
proliferation	O
by	O
cell	B:C0242481
viability	I:C0242481
assays	I:C0242481
.	O

To	O
improve	O
the	O
affinity	O
of	O
these	O
positive	O
hit	O
compounds	O
,	O
a	O
homology	B:C1512489
model	I:C1512489
of	O
human	O
NTR1	I:C1741785
was	O
built	O
on	O
the	O
basis	O
of	O
the	O
crystal	O
structure	I:C0230587
of	O
rat	O
NTR1	I:C1738937
.	O

To	O
improve	O
the	O
affinity	O
of	O
these	O
positive	O
hit	O
compounds	O
,	O
a	O
homology	O
model	I:C1512489
of	O
human	B:C1741785
NTR1	I:C1741785
was	O
built	O
on	O
the	O
basis	O
of	O
the	O
crystal	O
structure	I:C0230587
of	O
rat	O
NTR1	I:C1738937
.	O

To	O
improve	O
the	O
affinity	O
of	O
these	O
positive	O
hit	O
compounds	O
,	O
a	O
homology	O
model	I:C1512489
of	O
human	O
NTR1	I:C1741785
was	O
built	O
on	O
the	O
basis	O
of	O
the	O
crystal	B:C0230587
structure	I:C0230587
of	O
rat	O
NTR1	I:C1738937
.	O

To	O
improve	O
the	O
affinity	O
of	O
these	O
positive	O
hit	O
compounds	O
,	O
a	O
homology	O
model	I:C1512489
of	O
human	O
NTR1	I:C1741785
was	O
built	O
on	O
the	O
basis	O
of	O
the	O
crystal	O
structure	I:C0230587
of	O
rat	B:C1738937
NTR1	I:C1738937
.	O

The	O
hit	O
compounds	O
will	O
be	O
further	O
optimized	O
on	O
the	O
basis	O
of	O
the	O
structure	B:C0026383
of	O
the	O
hNTR1	O
receptor	I:C1741785
to	O
be	O
the	O
targets	O
for	O
drugs	O
directed	O
against	O
diseases	O
associated	O
with	O
human	O
NTR1	I:C1741785
.	O

The	O
hit	O
compounds	O
will	O
be	O
further	O
optimized	O
on	O
the	O
basis	O
of	O
the	O
structure	O
of	O
the	O
hNTR1	B:C1741785
receptor	I:C1741785
to	O
be	O
the	O
targets	O
for	O
drugs	O
directed	O
against	O
diseases	O
associated	O
with	O
human	O
NTR1	I:C1741785
.	O

The	O
hit	O
compounds	O
will	O
be	O
further	O
optimized	O
on	O
the	O
basis	O
of	O
the	O
structure	O
of	O
the	O
hNTR1	O
receptor	I:C1741785
to	O
be	O
the	O
targets	O
for	O
drugs	B:C1254351
directed	O
against	O
diseases	O
associated	O
with	O
human	O
NTR1	I:C1741785
.	O

The	O
hit	O
compounds	O
will	O
be	O
further	O
optimized	O
on	O
the	O
basis	O
of	O
the	O
structure	O
of	O
the	O
hNTR1	O
receptor	I:C1741785
to	O
be	O
the	O
targets	O
for	O
drugs	O
directed	O
against	O
diseases	B:C0012634
associated	O
with	O
human	O
NTR1	I:C1741785
.	O

The	O
hit	O
compounds	O
will	O
be	O
further	O
optimized	O
on	O
the	O
basis	O
of	O
the	O
structure	O
of	O
the	O
hNTR1	O
receptor	I:C1741785
to	O
be	O
the	O
targets	O
for	O
drugs	O
directed	O
against	O
diseases	O
associated	O
with	O
human	B:C1741785
NTR1	I:C1741785
.	O

The	O
results	O
demonstrate	O
that	O
the	O
method	O
we	O
used	O
is	O
valid	O
,	O
which	O
will	O
be	O
treated	O
as	O
a	O
useful	O
tool	O
to	O
search	O
for	O
the	O
agonists	B:C2987634
or	O
antagonists	O
of	O
our	O
interested	O
target	O
protein	I:C0033684
.	O

The	O
results	O
demonstrate	O
that	O
the	O
method	O
we	O
used	O
is	O
valid	O
,	O
which	O
will	O
be	O
treated	O
as	O
a	O
useful	O
tool	O
to	O
search	O
for	O
the	O
agonists	O
or	O
antagonists	B:C0243076
of	O
our	O
interested	O
target	O
protein	I:C0033684
.	O

The	O
results	O
demonstrate	O
that	O
the	O
method	O
we	O
used	O
is	O
valid	O
,	O
which	O
will	O
be	O
treated	O
as	O
a	O
useful	O
tool	O
to	O
search	O
for	O
the	O
agonists	O
or	O
antagonists	O
of	O
our	O
interested	O
target	B:C0033684
protein	I:C0033684
.	O

Moreover	O
,	O
the	O
compound	O
we	O
tested	O
may	O
provide	O
a	O
hopeful	O
clue	O
for	O
treating	O
the	O
diseases	B:C0012634
related	O
with	O
human	O
NTR1	I:C1741785
.	O

Moreover	O
,	O
the	O
compound	O
we	O
tested	O
may	O
provide	O
a	O
hopeful	O
clue	O
for	O
treating	O
the	O
diseases	O
related	O
with	O
human	B:C1741785
NTR1	I:C1741785
.	O

